Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioNTech SE

99.40
-5.9550-5.65%
Volume:458.38K
Turnover:46.37M
Market Cap:23.83B
PE:-45.91
High:104.76
Open:103.53
Low:99.25
Close:105.35
Loading ...

GeoVax Response to WHO's Third Declaration of Mpox as a Public Health Emergency of International Concern

NewMediaWire
·
28 Feb

Invivyd (NasdaqGM:IVVD) Surges 198% After Positive Results From VYD2311 COVID-19 Trial

Simply Wall St.
·
28 Feb

Novavax Reports Smaller Q4 Loss, Shifts Focus From Commercializing COVID-19 Vaccine To Maximize Value

Benzinga
·
28 Feb

CVS Pharmacy® introduces enhanced flu testing and treatment offerings

PR Newswire
·
27 Feb

Deutsche Pfandbriefbank (0R9K) Receives a Buy from Warburg Research

TIPRANKS
·
27 Feb

Medibank Announces $160 Million Customer Give Back Amid COVID-19 Support

TIPRANKS
·
27 Feb

BioNTech SE (BNTX): Among the Best Vaccine Stocks to Buy According to Hedge Funds

Insider Monkey
·
26 Feb

IMUNON Announces New Immunogenicity Data from Phase 1 Clinical Trial of Its DNA Vaccine in Treatment of COVID-19

GlobeNewswire
·
26 Feb

OraSure Reports Fourth Quarter 2024 Financial Results

GlobeNewswire
·
26 Feb

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Business Wire
·
24 Feb

Invivyd’s Strategic Positioning and Growth Potential in COVID-19 Prophylaxis Market: A Buy Rating Despite Regulatory Challenges

TIPRANKS
·
24 Feb

GeoVax Highlights the Role of MVA-Based Vaccines in Advancing Public Health Preparedness

NewMediaWire
·
24 Feb

Vaccine Stocks Rise as Chinese Scientists Discover a New Coronavirus

Zacks
·
24 Feb

Morgan Stanley Keeps Their Buy Rating on BioNTech SE (BNTX)

TIPRANKS
·
24 Feb

Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version

Benzinga
·
24 Feb

Invivyd Shares Down as Regulators Decline Expanded Use for Covid-19 Treatment

Dow Jones
·
24 Feb